Silver

Silver

SCHEMBL1177409

O=S(=O)([O-])c1ccccc1.[Ag+]

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Silver. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 2/20 0.55
▸ CA1 P00915 3/20 0.50
▸ CA2 P00918 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ CA12 O43570 2/20 0.50
▸ CA9 Q16790 2/20 0.50
▸ TDP1 Q9NUW8 2/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ CA3 P07451 1/20 0.50
▸ CA4 P22748 1/20 0.50
▸ CA6 P23280 1/20 0.50
▸ CA5A P35218 1/20 0.50
▸ CA7 P43166 1/20 0.50
▸ PLA2G7 Q13093 1/20 0.50
▸ CA13 Q8N1Q1 1/20 0.50
▸ CA14 Q9ULX7 1/20 0.50
▸ CA5B Q9Y2D0 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ DUSP3 P51452 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4312434 0.94 HTR6 (0.55) HTR6CA1CA2ALDH1A1CA12
SCHEMBL2310892 0.94 HTR6 (0.55) HTR6CA1CA2ALDH1A1CA12
SCHEMBL20583771 0.94 HTR6 (0.55) HTR6CA1CA2ALDH1A1CA12
SCHEMBL17942459 0.94 HTR6 (0.55) HTR6CA1CA2ALDH1A1CA12
SCHEMBL20533805 0.94 HTR6 (0.55) HTR6CA1CA2ALDH1A1CA12
Potassium Ion SCHEMBL132447 0.94 HTR6 (0.55) HTR6CA1CA2ALDH1A1CA12
SCHEMBL8622107 0.94 HTR6 (0.55) HTR6CA1CA2ALDH1A1CA12
SCHEMBL20533807 0.94 HTR6 (0.55) HTR6CA1CA2ALDH1A1CA12
SCHEMBL6916781 0.94 HTR6 (0.55) HTR6CA1CA2ALDH1A1CA12
SCHEMBL8374927 0.94 CA1 (0.57) HTR6CA1CA2ALDH1A1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3347309-B1 METHODS FOR OBTAINING SALTS OF SILVER(II) AND HYDRATES THEREOF, PRODUCTS OBTAINED BY THE METHODS AND USE OF THE SAME UNIV WARSZAWSKI (PL) 2022-07-20 — — EP claimed
US-20180352816-A1 COMPOSITION FOR CROP CARE AND PROTECTION ALPHA BIOPESTICIDES LIMITED (GB) 2018-12-13 — — US claimed
EP-3383177-A1 COMPOSITION FOR CROP CARE AND PROTECTION Alpha Biopesticides Limited (GB) 2018-10-10 — — EP claimed
WO-2017092978-A1 COMPOSITION FOR CROP CARE AND PROTECTION ALPHA BIOPESTICIDES LIMITED (GB) 2017-06-08 — — WO claimed
EP-4739113-A1 COMPOSITION FOR USE IN AGRICULTURE Bayer Aktiengesellschaft (DE) 2026-05-13 — — EP disclosed
US-12616995-B2 Methods for producing overt security features exhibiting one or more indicia SICPA HOLDING SA (CH) 2026-05-05 — — US disclosed
US-12538926-B2 Combination of bacterial biological control agent and fatty acids BAYER AKTIENGESELLSCHAFT (DE) 2026-02-03 — — US disclosed
US-12515253-B2 Compositions, comprising silver nanoplatelets BASF SE (DE) 2026-01-06 — — US disclosed
US-12507693-B2 Active compound combinations comprising fatty acids BAYER AKTIENGESELLSCHAFT (DE) 2025-12-30 — — US disclosed
EP-4433547-B1 METHODS FOR PRODUCING OVERT SECURITY FEATURES EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2025-12-24 — — EP disclosed
US-20250121405-A1 METHODS FOR PRODUCING OVERT SECURITY FEATURES EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2025-04-17 — — US disclosed
US-12215242-B2 UV-VIS radiation curable security inks for producing dichroic security features SICPA HOLDING SA (CH) 2025-02-04 — — US disclosed
WO-1991010165-A1 IMPROVED PERFORMANCE OF PHOTOGRAPHIC EMULSIONS AT HIGH SILVER ION ACTIVITIES EASTMAN KODAK COMPANY (US) 1991-07-11 — — WO disclosed
US-4452813-A BENZENESULFONYLOXY-CYCLOHEXYLALKANONES TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) 1984-06-05 — — US disclosed
US-4371710-A CEPHALOSPORINS SAGAMI CHEMICAL RESEARCH CENTER (JP) 1983-02-01 — — US disclosed
US-4359425-A OF A DIAMONO FUSED SATURATED HYDROCARBON RING, HAVING ANTITUMOR ACTIVITY SHIONOGI & CO., LTD. (JP) 1982-11-16 — — US disclosed
US-4324741-A PERFLUOROALKYL GROUP-INTRODUCING AGENTS SAGAMI CHEMICAL RESEARCH CENTER (JP) 1982-04-13 — — US disclosed
US-4258129-A IMPROVE GREEN SHELF LIFE FUJI PHOTO FILM CO., LTD. (JP) 1981-03-24 — — US disclosed
US-4211839-A SILVER HALIDE AND ORGANIC SILVER SALT PREPARED IN AN IMINO COMPOUND FUJI PHOTO FILM CO., LTD. (JP) 1980-07-08 — — US disclosed
US-4188212-A BEZNOTRIAZOLE FUJI PHOTO FILM CO., LTD. (JP) 1980-02-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12538926-B2 Combination of bacterial biological control agent and fatty acids PFAS, O60361, FADS2 HTR6 4505/4885CA1 2575/4885CA2 1541/4885
US-12507693-B2 Active compound combinations comprising fatty acids FAAH2, FAAH, PLA2G2D HTR6 2106/4885CA1 1114/4885CA2 806/4885
US-12616995-B2 Methods for producing overt security features exhibiting one or more indicia ATG4B, TPM4, ATG4A HTR6 3512/4885CA1 1197/4885CA2 853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback